Cáncer renal subgrupos de pacientes y poblaciones especiales: ¿qué hemos aprendido? - page 2

DISCLOSURES

•

Advisory boards

: Pfizer, Novartis, BMS, Roche, Bayer.

•

Honoraria (speaker)

: Pfizer, Novartis.

•

Travel expenses

: Pfizer, Novartis, Bayer.

•

Clinical trials

: Pfizer Roche

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1 3,4,5,6,7,8,9,10,11,12,...84